Survival of pancreatic cancer cells lacking KRAS function
Sign Up to like & getrecommendations! Published in 2017 at "Nature Communications"
DOI: 10.1038/s41467-017-00942-5
Abstract: Activating mutations in the proto-oncogene KRAS are a hallmark of pancreatic ductal adenocarcinoma (PDAC), an aggressive malignancy with few effective therapeutic options. Despite efforts to develop KRAS-targeted drugs, the absolute dependence of PDAC cells on… read more here.
Keywords: pdac cells; lacking kras; pancreatic cancer; cancer cells ... See more keywords